USPTO serial 97144804
T2PD
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARPER, HANNAH B
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with T2PD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Hultquist
STEVEN J. HULTQUIST HULTQUIST, PLLC510 MEADOWMONT VILLAGE CIRCLE, PMB #363CHAPEL HILL, NC 27517UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; anti-cancer preparations; pharmaceutical compounds for treating cancer; drugs for medical purposes, namely, pharmaceutical drugs for the prevention and treatment of cancer; medicines for human purposes, namely, for the prevention and treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; pharmaceutical preparations for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the prevention and treatment of cancer; antibody drug conjugates for medical purposes, namely, for the prevention and treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 20, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 20, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 16, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 21, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 21, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 1, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2021 | NWAP | NEW APPLICATION ENTERED | — |